CLINICAL_TRIALS
trial_result
· 2025-11-21
Clinical Trial Update: Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus [Phase 2]
Summary
Phase 2 trial results evaluating dupilumab for moderate to severe chronic hepatic pruritus have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Pruritus | Phase 2 | Status: COMPLETED | Results posted: 2025-11-21